Karyopharm Therapeutics Inc (KPTI)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current KPTI market cap is 83.52M. The company's latest EPS is USD -1.1419 and P/E is -0.60.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 36.01M | 33.75M | 33.13M | 42.79M | 38.78M |
| Operating Income | -31.26M | -37.81M | -33.76M | -28.12M | -26.28M |
| Net Income | -34.51M | -41.84M | -37.36M | 23.79M | -32.07M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 40.89M | 108.09M | 209.82M | 157.07M | 146.03M |
| Operating Income | -189.28M | -171.85M | -98.27M | -142.2M | -129.54M |
| Net Income | -199.59M | -196.27M | -124.09M | -165.29M | -143.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 269.96M | 240.44M | 204.46M | 213.98M | 189.48M |
| Total Liabilities | 370.36M | 376.64M | 373.41M | 346.12M | 349.12M |
| Total Equity | -100.4M | -136.21M | -168.96M | -132.14M | -159.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 294.96M | 313.05M | 305.31M | 358.17M | 240.44M |
| Total Liabilities | 245.19M | 262.5M | 384.98M | 374.83M | 376.64M |
| Total Equity | 49.77M | 50.55M | -79.67M | -16.66M | -136.21M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -74.14M | -92.72M | -43.73M | -82.22M | -101.68M |
| Investing | -18.9M | 7.94M | 21.94M | 73.2M | 80.68M |
| Financing | 860k | 1.12M | N/A | 40.97M | 40.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -190.82M | -160.23M | -107.12M | -149.55M | -92.72M |
| Investing | 78.45M | -53.69M | 141.84M | -104.26M | 7.94M |
| Financing | 124.31M | 172.08M | 73.65M | 193.74M | 1.12M |
| Market Cap | 83.52M |
| Price to Earnings Ratio | -0.60 |
| Price to Sales Ratio | 0.58 |
| Price to Cash Ratio | 1.63 |
| Price to Book Ratio | -0.63 |
| Dividend Yield | - |
| Shares Outstanding | 125.31M |
| Average Volume (1 week) | 1.38M |
| Average Volume (1 Month) | 920.6k |
| 52 Week Change | -15.64% |
| 52 Week High | 1.95 |
| 52 Week Low | 0.65 |
| Spread (Intraday) | 0.01 (1.86%) |
| Company Name | Karyopharm Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.karyopharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
